[First national Enantone Symposium. Progress in therapy of prostatic cancer. Multicenter study: long-term follow-up].
Fornara
P
P
D000368:Aged; D000970:Antineoplastic Agents; D003692:Delayed-Action Preparations; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006801:Humans; D007279:Injections, Subcutaneous; D016729:Leuprolide / Q000008:administration & dosage*; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000401:mortality / Q000628:therapy*; D011471:Prostatic Neoplasms / Q000401:mortality / Q000628:therapy*; D015996:Survival Rate
D000970:Antineoplastic Agents; D003692:Delayed-Action Preparations; D016729:Leuprolide
Erstes nationales Enantone Symposium. Fortschritte in der Therapie des Prostatakarzinoms. Multizenter-Studie: Langzeitverlaufskontrolle.